Merck Reports 12.9% Sales Growth in 2022 Annual Report
German major Merck (NYSE: MRK) released its 2022 annual report this week, showing a robust...
Fineline Cube
NHSA Releases Guidelines on Drug Procurement and Pricing Management
The National Healthcare Security Administration (NHSA) has released a notification regarding provincial centralized procurement and...
Kinnjiu Biopharma Initiates Global Phase I Study for Exarafenib
Shanghai-based Kinnjiu Biopharma Inc. has announced the first subject dosing in the global multi-center Phase...
Zai Lab Reports 2022 Financial Results with Revenue Growth
China-based Zai Lab Limited (NASDAQ: ZLAB, HKG: 9688) has announced its full-year 2022 financial results,...
Pengyang Yiliao Raises Series B+ Funds for Cardiovascular Product Development
Pengyang Yiliao, a Beijing-based developer and manufacturer of cardiovascular technology, has reportedly raised “tens of...
Zhejiang Medicine’s ARX788 Shows Positive Results in Breast Cancer Study
China-based Zhejiang Medicine Co., Ltd (SHA: 600216) has announced positive results from a Phase II/III...
Glowe Raises Series A+ Funding to Expand AIGC in Mental Health
Glowe, an online psychological consultation platform based in Guangdong, has reportedly raised “tens of millions”...
Geneus Tech Secures Funding for Gseq500 Gene Sequencer Production
Geneus Tech, a Shenzhen-based developer and manufacturer of gene sequencers, has reportedly raised an undisclosed...
Alphamab Oncology Partners with Stemirna for BsAb and mRNA Vaccine Development
China-based Alphamab Oncology (HKG: 9966) has announced a strategic partnership with Shanghai-based mRNA drug developer...
CanSino Biologics’ Inhalable COVID-19 Vaccine Gets EUA in Indonesia
China-based CanSino Biologics (SHA: 688185, HKG: 6185) has announced that it has received emergency use...
BeiGene Reports Outstanding Q4 and Full-Year 2022 Financial Results
BeiGene, Ltd. (NASDAQ: BGNE, HKG: 6160, SHA: 688235) has released financial results for the Q4...
Viatris Reports Q4 2022 Results, Highlights China Growth
US-based generics giant Viatris Inc. (NASDAQ: VTRS) has released its Q4 2022 financial report. The...
China Performs First AB-BNCT Procedures Outside Japan
The first accelerator-based boron neutron capture therapy (AB-BNCT) procedures have been performed in China by...
HutchMed Reports 2022 Financial Results with Revenue Growth
Hutchison China Meditech (HutchMed; HKG: 0013, NASDAQ: HCM) has released its financial results for the...
3SBio’s Nalfurafine Tablets Accepted for Review by NMPA for Chronic Liver Disease
China-based 3SBio Inc. (HKG: 1530) has announced that a clinical trial filing for its nalfurafine...
3SBio Terminates Distribution Agreement with AstraZeneca for Byetta
China-based 3SBio Inc. (HKG: 1530) has announced the termination of a distribution agreement with UK...
JW Therapeutics Initiates Clinical Study for JWATM214 in Advanced Hepatocellular Carcinoma
China-based JW Therapeutics (HKG: 2126) has announced the initiation of a clinical study for its...
FibroGen Reports Q4 2022 Financial Results with Revenue Growth
US-based FibroGen Inc. (FGEN) has released its Q4 2022 financial results. The company reported global...
China Issues New Ethical Review Measures for Life Sciences and Medical Research
The National Health Commission, Ministry of Education, Ministry of Science and Technology, and National Administration...
Bayer Reports 2022 Sales Growth, Highlights New Drug Performances
Germany-based Bayer (ETR: BAYN) released its 2022 annual report this week, revealing a global sales...